PHARMout Executive Team
Patrick Lin, Ph.D.
Dr. Lin has 30 years of scientific and managerial working experience in pharmaceutical research for both drug discovery and drug development. After earning his Ph.D. in analytical medicinal chemistry and constructing the first LCMS with electrospray interface at Purdue University for cataract proteomics research, Dr. Lin worked at MDS Pharma Services for 10 years as the Director and Senior Global Research Leader. He developed and validated GLP bioanalytical methods with more than one hundred publications and involved drug discovery and development for numerous pharmaceutical and biotech companies. Prior to partnering PHARMout Laboratories, Dr. Lin was the VP of Elim Biopharm to lead bioanalysis, and implement NextGen lab automation. He also previously was the Senior Director at Xenobiotic Laboratories, at Intertek to develop GLP/OECD facilities in China, and the co-founder of iPhase Pharma in Beijing, China. Dr. Lin is a member of SQA, ASMS and AAPS.
Allan Xu, Ph.D.
Dr. Xu obtained his PhD in biochemistry from University of Maryland at College Park in 1987. He has worked at both public and private sector laboratories for more than 30 years. Allan has pioneered the use and exploitation of mass spectrometry to provide analytical support for forensic, endocrinology, clinical toxicology, and pharmaceutical PK sample analysis. He is a co-founder at Keystone Bioanalytical, Inc. a LC/MS./MS based CRO located near Philadelphia where he held the position of Lab. Director since 1996. His main interest is using the most advance technology for small molecule/biomarker quantitation.
Copyright © 2020 Pharmout Laboratories, Inc. All rights reserved.